Shares of Guardian Capital Group Limited (TSE:GCG.A – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$44.19 and traded as low as C$40.50. Guardian Capital Group shares last traded at C$40.71, with a volume of 5,758 shares trading hands.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the company. Scotiabank decreased their target price on Guardian Capital Group from C$56.00 to C$55.00 and set an “outperform” rating for the company in a research note on Monday, August 12th. BMO Capital Markets decreased their price target on Guardian Capital Group from C$56.00 to C$50.00 and set an “outperform” rating for the company in a research report on Monday, August 12th.
View Our Latest Stock Analysis on Guardian Capital Group
Guardian Capital Group Stock Performance
Guardian Capital Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, July 18th. Stockholders of record on Thursday, July 18th were paid a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 3.64%. The ex-dividend date was Thursday, July 11th. Guardian Capital Group’s dividend payout ratio (DPR) is presently 60.91%.
Guardian Capital Group Company Profile
Guardian Capital Group Limited, together with its subsidiaries, operates as a diversified financial services company in Canada, the United Kingdom, the United States, and the Caribbean. It manages institutional assets for pension plans, insurers, foundations, endowments, third-party mutual funds, and ETFs; and provides private wealth management services to individuals, families, and charitable organizations.
See Also
- Five stocks we like better than Guardian Capital Group
- How to Use the MarketBeat Excel Dividend Calculator
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Effectively Use the MarketBeat Ratings Screener
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Want to Profit on the Downtrend? Downtrends, Explained.
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Guardian Capital Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Capital Group and related companies with MarketBeat.com's FREE daily email newsletter.